Search for: [Abstract = "containing one active substance \(tacrolimus\) with efficacy in ACD proven in moderate quality trials. Among drugs recommended by experts for seborrhoeic dermatitis \(SD\), there were 185 medicinal products registered in Poland with 27 active substances, including 68 preparations of 19 active substances with the official indication for the treatment of SD. Among drugs both recommended and registered in Poland for the SD treatment, there were 18 medicinal products containing active substances with efficacy proven in high\- or moderate quality clinical trials, including 11 topical preparations of ketoconazole, 3 topical ciclopirox olamine preparations, as well as 4 out of 32 glucocorticoid \(GCS\) preparations registered for this indication \(1 active substance – fluocinolone acetonide\). Among recommended medicinal products available in Poland, but not registered for the treatment of seborrhoeic dermatitis, there were 24 medicinal products containing 3 active substances \(cicropilox olamine, pimecrolimus, oral terbinafine\) with efficacy proven in high\- or moderate quality clinical trials. The reimbursement scheme for the indication “seborrhoeic dermatitis” covered six topical GCS preparations \(4 active substances, none with efficacy confirmed in high or moderate quality trials\) and 9 oral GCS preparations \(4 active substances, none with confirmed effectiveness\). Among drugs recommended by expert bodies for the treatment of hand eczema \(HE\), 382 medicinal products with 41 active substances, and 21 emollients were licensed to the Polish market. Out of these, only 6 local GCS preparations with 2 active substances \(betamethasone, diflucortolone valerate\), one oral preparation of the retinoid alitretinoin \(9\-cis\-retinoic acid\), and one emollient had the official indication for the treatment of this condition. Only one medicinal product registered for treating hand eczema contained an active substance with effectiveness confirmed in high\- or moderate quality clinical studies \(oral alitretinoin, high quality evidence\). No medicinal products were placed on the reimbursement list with the indication \"hand eczema\". Among medicinal products available in Poland but not registered for the"]
